Xilio Therapeutics
XLO
#9732
Rank
NZ$61.47 M
Marketcap
$1.19
Share price
-1.90%
Change (1 day)
-51.50%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -$5.02

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.52. In 2022 the company made an earnings per share (EPS) of -$5.79 a decrease over its 2021 EPS that were of -$5.55.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.02-13.27%
2022-$5.794.42%
2021-$5.55